SYNLAB AG
SYNLAB AG: Cinven announces public delisting acquisition offer | Conclusion of Delisting Agreement
SYNLAB AG / Key word(s): Delisting SYNLAB AG (“SYNLAB”; FSE: SYAB) has today signed a delisting agreement (“Delisting Agreement”) with Ephios Bidco GmbH, a subsidiary of Ephios Luxembourg S.à r.l., both holding companies controlled by investment funds advised by Cinven Limited.
Concurrently, Ephios BidCo GmbH announced its decision to make a public delisting acquisition offer to the shareholders of SYNLAB to acquire all shares outstanding of SYNLAB (“Offer”) not directly held by it. Ephios BidCo GmbH already holds approx. 86% of the voting rights in SYNLAB. The Offer will not be subject to any conditions. The Delisting Agreement provides that, subject to the review of the published offer document and within the scope of and in compliance with its legal obligations, SYNLAB will file an application for revocation of the admission of the SYNLAB shares to trading on the regulated market of the Frankfurt Stock Exchange prior to the expiry of the Acceptance Period. After the revocation of the listing has taken effect, SYNLAB’s shares will no longer be admitted to trading and traded on a domestic regulated market or a comparable market abroad. End of Inside Information
31-May-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | SYNLAB AG |
Moosacher Straße 88 | |
80809 Munich | |
Germany | |
Phone: | +49 1701183753 |
E-mail: | ir@synlab.com |
Internet: | www.synlab.com/ |
ISIN: | DE000A2TSL71 |
WKN: | A2TSL7 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1914941 |
End of Announcement | EQS News Service |
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden